RE: RE: RE: Licensing vs BuyoutAnswer, too many pumpers, but I definitely agree, there are very good possibilities here, still premature for licensing or buyout, maybe the day traders want you to believe that, so they can sell for tiny profits. Hang on until the news, let the chips fall, where they may. Id hope you wouldnt be holding onto so called cheap 30 cent shares by then. Results for mice dont always flow through to humans. If the drug shows very good promise like I think it does, then it is possible a canadian government agency may sponsor a small set of human trials. Too many here are counting on a buyout? or a licensing agreement. I believe in letting the tree grow, at least in this particular case, let management ride the pony as far as they can. I still believe company value could increase rapidly with very good success on the five dose study, and the move to animal testing... and final decision on human testing, maybe the maximum limit before very good offers for shares may appear. Still to introductory to me, for a big premium to pay, as the multinationals, at least to me can afford to wait, albeit at their own risk, as the milestones pass, the price goes up... good luck to all....